Quantcast

Bay State News

Tuesday, April 22, 2025

FDA conducted second highest number of inspections on Biologics companies in Massachusetts during January

Webp ijw6s7vbfr36c32lki2m95inya4m

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

In January, three Biologics companies received three FDA inspections in Massachusetts, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Massachusetts, equalling 30% of all inspections in January.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Massachusetts During January
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products1
Drug Quality Assurance1
Food Composition, Standards, Labeling and Econ11
Foodborne Biological Hazards42
Human Cellular, Tissue, and Gene Therapies2

MORE NEWS